英国医护人员的维生素 D 状况与 COVID-19 血清转换。
Vitamin D status and seroconversion for COVID-19 in UK healthcare workers.
机构信息
Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
Joint first authors.
出版信息
Eur Respir J. 2021 Apr 8;57(4). doi: 10.1183/13993003.04234-2020. Print 2021 Apr.
Abstract
摘要
[网页链接]
相似文献
1
Vitamin D status and seroconversion for COVID-19 in UK healthcare workers.
Eur Respir J. 2021 Apr 8;57(4). doi: 10.1183/13993003.04234-2020. Print 2021 Apr.
2
Genetic polymorphisms, vitamin D binding protein and vitamin D deficiency in COVID-19.
Eur Respir J. 2021 May 6;57(5). doi: 10.1183/13993003.04638-2020. Print 2021 May.
3
Genetic polymorphisms, vitamin D binding protein and vitamin D deficiency in COVID-19.
Eur Respir J. 2021 May 6;57(5). doi: 10.1183/13993003.00653-2021. Print 2021 May.
4
Vitamin D status: a U-shaped relationship for SARS-CoV-2 seropositivity in UK healthcare workers.
BMJ Open Respir Res. 2022 Sep;9(1). doi: 10.1136/bmjresp-2022-001258.
5
Vital D: A modifiable occupational risk factor of UK healthcare workers.
PLoS One. 2024 Apr 16;19(4):e0296247. doi: 10.1371/journal.pone.0296247. eCollection 2024.
6
[Longitudinal Monitoring of Seroconversion Status in SARS-CoV-2 RT-PCR Positive Healthcare Workers].
Mikrobiyol Bul. 2022 Jan;56(1):114-123. doi: 10.5578/mb.20229910.
7
Vitamin D and COVID-19 infection and mortality in UK Biobank.
Eur J Nutr. 2021 Feb;60(1):545-548. doi: 10.1007/s00394-020-02372-4. Epub 2020 Aug 26.
8
Seroprevalence of SARS-CoV-2 antibodies among hospital workers in a German tertiary care center: A sequential follow-up study.
Int J Hyg Environ Health. 2021 Mar;232:113671. doi: 10.1016/j.ijheh.2020.113671. Epub 2020 Nov 30.
9
Healthcare institutions' recommendation regarding the use of FFP-2 masks and SARS-CoV-2 seropositivity among healthcare workers: a multicenter longitudinal cohort study.
Antimicrob Resist Infect Control. 2022 Jan 10;11(1):6. doi: 10.1186/s13756-021-01047-x.
10
Patients hospitalized with COVID-19 have low levels of 25-hydroxyvitamin D.
Endocrine. 2021 Feb;71(2):267-269. doi: 10.1007/s12020-020-02597-7. Epub 2021 Jan 16.
引用本文的文献
1
SARS-CoV2 variants differentially impact on the plasma metabolome.
Metabolomics. 2025 Apr 5;21(2):50. doi: 10.1007/s11306-025-02238-y.
2
Vitamin D as an Adjuvant Immune Enhancer to SARS-Cov-2 Vaccine.
Curr Microbiol. 2025 Feb 7;82(3):122. doi: 10.1007/s00284-025-04095-3.
3
Vitamin D deficiency and duration of COVID-19 symptoms in UK healthcare workers.
Front Med (Lausanne). 2024 Nov 25;11:1494129. doi: 10.3389/fmed.2024.1494129. eCollection 2024.
4
Vitamin D Binding Protein: A Potential Factor in Geriatric COVID-19 Acute Lung Injury.
J Inflamm Res. 2024 Jul 8;17:4419-4429. doi: 10.2147/JIR.S470097. eCollection 2024.
5
Vitamin D status: a U-shaped relationship for SARS-CoV-2 seropositivity in UK healthcare workers.
BMJ Open Respir Res. 2022 Sep;9(1). doi: 10.1136/bmjresp-2022-001258.
6
Serious vitamin D deficiency in healthcare workers during the COVID-19 pandemic.
BMJ Nutr Prev Health. 2022 Jan 4;5(1):134-136. doi: 10.1136/bmjnph-2021-000364. eCollection 2022.
7
Vitamin D and COVID-19-Revisited.
J Intern Med. 2022 Oct;292(4):604-626. doi: 10.1111/joim.13536. Epub 2022 Jul 15.
8
Vitamin D: A Potential Mitigation Tool for the Endemic Stage of the COVID-19 Pandemic?
Front Public Health. 2022 Jun 10;10:888168. doi: 10.3389/fpubh.2022.888168. eCollection 2022.
9
COVID-19 and Vitamin D- a Systematic Review.
Zdr Varst. 2022 Mar 21;61(2):124-132. doi: 10.2478/sjph-2022-0017. eCollection 2022 Jun.
10
Relationship of anti-SARS-CoV-2 IgG antibodies with Vitamin D and inflammatory markers in COVID-19 patients.
Sci Rep. 2022 Apr 5;12(1):5699. doi: 10.1038/s41598-022-09785-7.
Zotero 插件